Your browser is no longer supported. Please, upgrade your browser.
InVivo Therapeutics Holdings Corp.
Index- P/E- EPS (ttm)-0.34 Insider Own2.17% Shs Outstand34.26M Perf Week8.19%
Market Cap18.71M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float33.52M Perf Month-11.03%
Income-9.20M PEG- EPS next Q- Inst Own11.60% Short Float8.97% Perf Quarter-17.01%
Sales- P/S- EPS this Y96.30% Inst Trans-12.27% Short Ratio4.53 Perf Half Y-17.49%
Book/sh0.61 P/B0.91 EPS next Y- ROA-37.10% Target Price- Perf Year-4.98%
Cash/sh0.63 P/C0.89 EPS next 5Y- ROE-41.30% 52W Range0.49 - 2.00 Perf YTD-31.49%
Dividend- P/FCF- EPS past 5Y73.20% ROI- 52W High-72.26% Beta1.09
Dividend %- Quick Ratio10.60 Sales past 5Y- Gross Margin- 52W Low13.24% ATR0.04
Employees6 Current Ratio10.60 Sales Q/Q- Oper. Margin- RSI (14)46.91 Volatility10.36% 7.16%
OptionableNo Debt/Eq0.00 EPS Q/Q84.70% Profit Margin- Rel Volume1.63 Prev Close0.56
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume664.18K Price0.55
Recom- SMA20-0.33% SMA50-8.77% SMA200-28.08% Volume1,082,571 Change-0.79%
Jul-31-17Downgrade Raymond James Outperform → Mkt Perform
May-05-17Downgrade Raymond James Strong Buy → Outperform
Jul-21-16Initiated Ladenburg Thalmann Buy
Jul-07-16Initiated Raymond James Strong Buy $13
Sep-09-21 08:00AM  
Sep-08-21 08:00AM  
Jul-19-21 06:13AM  
Jul-13-21 09:13AM  
Jul-06-21 08:05AM  
Jun-13-21 11:22PM  
Mar-12-21 08:00AM  
Mar-05-21 08:00AM  
Feb-16-21 08:00AM  
Jan-18-21 05:47AM  
Oct-26-20 04:15PM  
Oct-22-20 09:15AM  
Sep-11-20 08:30AM  
Apr-17-20 12:19PM  
Apr-15-20 07:30PM  
Mar-11-20 04:27PM  
Mar-06-20 09:15AM  
Feb-03-20 04:30PM  
Nov-22-19 04:30PM  
Nov-21-19 08:00AM  
Nov-18-19 08:15AM  
Nov-12-19 08:00AM  
Oct-29-19 10:51AM  
Oct-22-19 08:00AM  
Jul-16-19 08:00AM  
Jul-12-19 08:00AM  
Jun-14-19 08:00AM  
May-29-19 02:54PM  
Apr-17-19 08:00AM  
Apr-01-19 08:15AM  
Jan-14-19 08:00AM  
Nov-29-18 08:00AM  
Nov-19-18 09:00AM  
Nov-08-18 06:55PM  
Oct-02-18 08:00AM  
Oct-01-18 08:00AM  
Sep-28-18 08:05AM  
Aug-28-18 08:00AM  
Aug-07-18 07:42PM  
Jun-25-18 04:05PM  
Jun-21-18 09:00AM  
May-24-18 10:35AM  
May-07-18 06:44PM  
Apr-18-18 08:20AM  
Apr-09-18 08:00AM  
Mar-19-18 08:00AM  
Mar-12-18 08:35AM  
Mar-09-18 10:34AM  
Mar-08-18 08:00AM  
Feb-05-18 08:00AM  
Jan-29-18 07:00AM  
Jan-26-18 08:00AM  
Jan-03-18 08:00AM  
Dec-18-17 08:00AM  
Nov-06-17 08:00AM  
Oct-30-17 06:03PM  
Oct-11-17 10:14AM  
Oct-10-17 08:00AM  
Sep-20-17 08:00AM  
Sep-05-17 08:00AM  
Aug-29-17 05:59PM  
Aug-28-17 04:30PM  
Aug-10-17 09:00AM  
Aug-09-17 11:37PM  
Aug-08-17 06:00PM  
Aug-01-17 08:00AM  
Jul-31-17 12:46PM  
Jul-12-17 08:00AM  
Jul-11-17 08:00AM  
Jul-10-17 08:00AM  
Jun-29-17 08:00AM  
Jun-28-17 09:45AM  
Jun-27-17 08:00AM  
Jun-20-17 08:00AM  
Jun-12-17 08:00AM  
Jun-01-17 08:00AM  
May-30-17 08:00AM  
May-09-17 08:00AM  
May-08-17 08:00AM  
May-05-17 05:03AM  
May-04-17 04:36PM  
Apr-20-17 08:00AM  
Apr-10-17 08:00AM  
Apr-05-17 08:00AM  
Mar-31-17 04:04PM  
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.